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Abstract: Congenital nasolacrimal duct obstruction (CNLDO) is a common condition causing
excessive tearing or mucoid discharge from the eyes, due to blockage of the nasolacrimal duct
system. Nasolacrimal duct obstruction affects as many as 20% children aged <1 year worldwide and
is often resolved without surgery. Available treatment options are conservative therapy, including
observation, lacrimal sac massage and antibiotics, and invasive therapy. Observation, combined with
conservative options, seems to be the best option in infants aged <1 year. Meanwhile, in children aged
>1 year, nasolacrimal probing successfully addresses most obstructions. However, the most favorable
timing for probing remains controversial. To alleviate persistent epiphora and mucous drainage
that is refractory to probing, repeat probing, silicone tube intubation, balloon catheter dilation or
dacryocystorhinostomy can be considered as available treatment options. Our review aims to provide
an update to CNDO management protocols.
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1. Introduction
Congenital nasolacrimal duct obstruction (CNLDO) is a common disorder in the pediatric
population, causing failure in the nasolacrimal duct drainage system and presenting clinically in
the overflow of tears, also called “epiphora” [1].
Epidemiological studies report that the prevalence of CNLDO ranges from 5% to 20% in the early
phase of childhood [2,3]. MacEwen et al. found that in a cohort of 4792 infants in Britain, the prevalence
of epiphora was approximately 20% in the first year of life, and almost 95% of this population showed
symptoms at one month of age [3]. The pathogenesis of CNLDO lies in a mechanical obstruction
located distally in the nasolacrimal duct (NLD) at the valve of Hasner, where this structure enters
the nose [4]. Furthermore, most of the evidence would show the main causes of obstruction as either
a pathological persistence of the membrane at the distal portion of the NLD, some bone abnormalities,
or a stenosis of the inferior meatus leading to a narrowing in the lacrimal drainage system [5,6].
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Moreover, the higher prevalence of CNLDO reported in premature infants compared with ones at
full-term suggests the importance of the physiological development of the nasolacrimal drainage
system during intrauterine life, in order to ensure the patency of the NLD [7].
The clinical presentation of the disease is mostly characterized by excessive tearing and ocular
mattering. Distal obstruction at the Hasner valve is more likely to cause a mucopurulent discharge,
whereas, when obstruction is near the nasolacrimal sac, (valve of Rosenmueller), it is more frequently
related to a watery discharge [8,9]. While usually unilateral, CNLDO occurs bilaterally in 20% of
cases [8]. The diagnosis of the disorder is confirmed by the fluorescein dye disappearance test,
which evaluates the clearance of the dye from the tear meniscus in both eyes over a 5-minute period [10].
However, other causes of epiphora in infants, such as infantile glaucoma and foreign body and corneal
infections should be carefully ruled out [11]. While bacteria overgrowth can occur in patients with
CNLDO, it is usually delimited in the NLD and only occasionally causes conjunctivitis [1,12].
More recently, a higher prevalence of anisometropic amblyopia has been demonstrated in children
with CLNDO (10–12%); thus in these patients, a complete eye examination, including cycloplegic
refraction, should be performed with a follow-up period of at least 3–4 years [13,14]. Several studies
have shown that CLNDO tends to naturally and spontaneously resolve itself within the first year
of life in most cases [15–19]; however, in some cases, this disorder may persist beyond the first
year of life, and for this reason, more practical guidelines for the management of CLNDO are
needed. In fact, many ophthalmologists agree with a conservative approach as a first-line strategy,
whereas a remarkable counterpart debate the primary importance of an early probing, the most
common invasive approach treating CLNDO [9,20]. Thus, the aim of this study is to describe two
different schools of thought in the management of this disorder and to better understand the role of
medical and the surgical treatments, with a focus on the modality and timing of interventions.
2. Medical Treatment
The conservative approach consists of simple observation and massage of the lacrimal sac, and the
application of topical antibiotics when a bacterial superinfection occurs.
2.1. Observation
Several studies have reported a high rate of spontaneous resolution of CLNDO within the first
year of age, ranging from 32% to 95% by the age of 13 months [4,16–19]. In 1985, Paul showed
a prevalence of spontaneous resolution in 15% of patients at three months, 45% at six months, 71% at
nine months and 93% at 12 months in a non-randomized prospective study [19]. However, if the
prevalence of resolution increases with time, most of the evidence describes higher spontaneous
resolution rates in the first months of life: 80–90% in the first trimester, 68–75% in the second and
ultimately 36–57% in the third [3,17,19]. Nelson et al. described a CLNDO resolution rate of 93% with
conservative management in children aged 8 months or less [15]. Similarly, Noda et al. reported the
patency of NLD in the population of Japanese infants treated with a non-invasive approach within
9 months of age [19]. Nonetheless, resolution of the disorder may occur even beyond the first year
of life [16,21]; in this regard Young et al. found that in a multicenter, randomized clinical trial (RCT),
the obstruction resolved spontaneously between the first and second year of life in 44% of the children
with CLNDO [22].
In addition, bilateral CLNDO, reported in a non-negligible percentage of children (14–33.8%), is likely
to reach a spontaneous resolution within the 3 months that the contralateral eye has recovered [23].
2.2. Massage of Lacrimal Sac
The massage of the lacrimal sac is a widely adopted conservative treatment modality, with the
aim of improving the chances of resolution provided by only observation. This maneuver was
first introduced in 1923 by Crigler, who elaborated a technique using a downward rotation of the
thumb over the tear sac in order to break the membranous obstruction by increasing the hydrostatic
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pressure [24]. Subsequently, in a randomized prospective trial, Kushner showed the efficacy of this
maneuver as compared to a simple massage or no massage at all [25]. Though some studies have
questioned the clinical effect of this maneuver on the resolution of CLNDO [26,27], a more recent
study published by Stolovitch et al. demonstrated the clinical efficacy of the Crigler maneuver
in a group of 742 children with CLNDO. The results showed a success rate of 56% after the first
attempt in children younger than 2 months, 46% in children aged 2 to 6, and 28% in children older
than 6 months. Thus, given its efficacy, safety, and nonetheless good compliance for the patients,
the authors recommended the Crigler maneuver as a first-line conservative approach for CNLDO,
even in children older than 6 months [28]. In support of this evidence, the Pediatric Eye Disease
Investigative Group (PEDIG) studied the cost-effectiveness of immediate office-based NLD probing in
comparison with a 6-month period of conservative management followed by deferred facility-probing
in a sample size of 163 children with CNLDO aged 6 to 10 months. This observational RCT revealed
that in almost two-thirds of the children, the obstruction was resolved in 6 months with non-surgical
management. Despite the encouraging results of a more conservative approach, the authors found
better cost-effectiveness in immediate probing and, nonetheless, said that they would not neglect the
possibility of office-based probing without the risks of a general anesthesia performed in the deferred
intervention [29].
Furthermore, a more recent study found a statistical difference in the resolution rate of CNLDO in
infants effectively treated with regular lacrimal sac massage in comparison with observed infants and
infants that did not have frequent lacrimal sac massages (96.2% vs. 77.7%, p = 0.001) [30]. These results
suggest the importance of the Crigler maneuver, the role of which should be emphasized to parents
because of the high success rate and the additional benefit afforded by the “wait and see” approach.
Ultimately, given the optimal CNLDO resolution rate, the good compliance in patients and the
consistent possibility of avoiding more invasive intervention such as probing, simple observation of
the infant in addition to the correct execution of the lacrimal sac massage should be considered as the
first-line treatment in the management of CNLDO in the first 12 months of life.
2.3. The Role of Antibiotics
Several studies have focused their attention on the use of antibiotic drops in combination with
conservative therapy for CNLDO [17,31,32]. However, there is no evidence of a significant clinical effect
of antibiotic eye drops in the resolution of the disorder [32,33]. Moreover, it has been demonstrated that
patients with CNLDO would not show differences in the bacterial flora composition of the conjunctiva
in comparison with normal subjects [34]. Thus, the administration of antibiotic drops should balance
the possibility of avoiding the local spread of an infectious process from the lacrimal sac with the risk
of developing resistant flora causing a NLD chronic infection. In fact, the irrational use of antibiotic
drops, especially in premature infants, not only would not promote CNLDO resolution, but also would
facilitate the overgrowth of resistant bacteria in the nasolacrimal system given the higher susceptibility
of these individuals [34,35].
On the other hand, the administration of topical antibiotic therapy has its rationale only when
symptoms of discharge are present [1,35]. Moreover, an infection of the nasolacrimal drainage system
may lead to severe complications such as orbital and preseptal cellulitis, in which urgent hospital
admission with intravenous antibiotic treatment is required [20].
In conclusion, most of the studies agree that antibiotic therapy is indicated only with the clinical
evidence of infection, but not in the conservative management of CLNDO.
2.4. Invasive Treatment
The first-line invasive treatment in the management of CLNDO consists of irrigation in conjunction
with probing. Other second-line strategies adopted in case of probing failure are repeated probing,
silicone tube intubation and balloon dilatation of the lacrimal drainage system.
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2.5. High-Pressure Irrigation
High-pressure irrigation, as the lacrimal sac massage, creates positive pressure in the nasolacrimal
system in order to resolve the obstruction and therefore should be considered as an intermediate
procedure between the conservative and the invasive management of CNLDO [36]. Several studies
reported that the overall success rate ranges from 33 to 100% [29,35]. In this regard, Alagoz et al.
showed a CNLDO resolution rate of 81.8% with high-pressure irrigation at the first attempt in children
aged 7 to 12 months and 76.5% in children aged 13 to 17 months. Moreover, although this treatment
modality is less invasive than probing, damage of the lacrimal canaliculus can occur during the
procedure with the canula [37]. In addition, a retrospective study by Isaza et al. revealed that probing
without irrigation was overall successful in 83.5% of children with CNLDO (respectively 90.2% in
children younger than 2 years and 78.9% in children older than 2 years), similarly the results shown
by traditional probing combined with this procedure [38]. Thus, as most of the evidence suggests,
high-pressure irrigation should be considered more as an ancillary procedure preceding probing,
which remains the first-line invasive treatment for CNLDO [35,36].
3. Primary Probing
Probing of the nasolacrimal system is traditionally the most commonly adopted surgical procedure
in the management of CLNDO [39–42]. This procedure, which requires passing a probe down to the
distal portion of the nasolacrimal system in order to break the obstruction, may be performed either in
office with only the administration of local anesthetics or in the operating room in a surgical facility
with general anesthesia [9]. In recent years, two different philosophies have been debating about the
optimal timing of intervention; the first one suggests an early primary probing (6–9 months) because
even if it is technically more challenging to manage an awake and often crying child, it would allow
for avoiding the risks of general anesthesia and, according to some authors, the potential development
of fibrosis due to the prolonged chronic inflammation of the NLD [20,23,43]. However, subsequent
studies found no presence of inflammatory-induced fibrosis in children with CNLDO [34]. On the
contrary, the second school of thought recommends a late primary probing (beyond 12 months),
since the procedure under general anesthesia requires less technical skills for inexperienced surgeons
and, more importantly, it has shown success rates comparable to the early intervention [21,22,44].
Primary early probing is typically performed under topical anesthesia in children younger
than 12 months; however most of the evidence suggests a resolution rate of CLNDO ranging from
75% to 89%, with comparable results in children older than 12 months [40,45,46]. Furthermore,
in two non-randomized, multicenter studies, PEDIG analyzed the clinical efficacy of early probing
in 304 children aged 6 to 15 months and revealed an overall success rate of 75% (95% CI, 70–80%),
with lower results in bilateral CLNDO compared to unilateral CLNDO (63% vs. 80%; relative risk
(RR) = 0.78) [46].
On the other hand, primary late probing has shown an optimal success rate (75–80%) comparable
with early probing, also in older children with CLNDO younger than 3 years old [47–50]. In particular,
several studies reported optimal results in children beyond the first year of age, with a resolution rate
ranging from 76.8% to 89% in children aged 13 to 18 months, 54% to 88.6% in children aged 18 to
24 months and 33% to 71.7% in children aged 24 to 36 months [51–53]. In line with this evidence,
Rajabi et al. reported in a non-randomized prospective, interventional study including 343 children
with CNLDO, an overall primary late probing success rate of 75.8%, more specifically 85% in children
aged 2 to 3 years old, 63% in children aged 3 to 4 years old, and 50% in children aged 4 to 5 years
old [54]. Moreover, in a retrospective study including 246 eyes of 177 children with CLNDO aged 0 to
9.8 years, Napier et al. reported a success rate of 76% of primary priming as a first-line intervention,
regardless of gender, age and complexity of obstruction [55].
The already-mentioned PEDIG randomized clinical trial comparing early office-based probing
with a 6-month period, followed by late probing in a surgical facility, reported similar resolution rates
between the two interventions. In this regard, the authors found that early probing reduced overall
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symptoms of 3 months and was slightly more cost-effective in comparison with the deferred procedure;
however, the possibility of resolving CLNDO in two thirds of the patients with only simple observation
should be carefully taken into consideration [29]. In fact, probing is an invasive and blind procedure,
which is not free from complications such as bleeding, damage of the nasolacrimal system and of the
adjacent structures and inflammation with subsequent NLD fibrosis [9]. Young et al. reported bleeding
from the lacrimal punctum during the procedure in 20% of patients caused by the formation of a false
passage [22].
More recently, endoscopy-assisted nasal probing has improved the success rate of this procedure
and at the same time has reduced the likelihood of complications [56–58]. The endoscopic technique
is performed under general anesthesia often through the multidisciplinary collaboration with other
specialists like otolaryngologists, allowing for a direct visualization of the nasolacrimal system and the
possibility to fracture the inferior turbinate in case of bone abnormalities [59,60]. Thus, given the
invasiveness and high skills required by this intervention, endoscopic nasal probing should be
considered an efficient second-line treatment for children with CLNDO.
In conclusion, probing has revealed promising results in the management of CLNDO, however
an open debate about the optimal timing of the intervention still persists. The risk-benefit ratio of early
probing should be thoroughly weighed, however, since the conservative treatment has shown to be
safe and effective in the majority of the patients and late probing offers comparable results with the
office-based procedure in children older than 12 months, acting as a convincing second-line strategy.
4. Repeated Probing
In the case of primary probing failure, patients usually develop excessive tearing and crusting
within 6 weeks of the intervention [1]. For this reason, repeating the procedure under general anesthesia
after a period of at least 1 month could be a viable option [36].
In this regard, PEDIG analyzed the clinical efficacy of repeated probing in children with relapsing
CNLDO aged 6 to 48 months in a multicenter, non-randomized, prospective study, visiting the
patients one month and six months after surgery, respectively; they found an overall success rate of
56% after the 6-month follow-up period [61], similar to the results reported by Kakowitz et al. with
a secondary probing resolution rate of 52% in children aged 6–18 months and 18% in children aged
18–24 months [51]. This evidence suggests an important reduction in the success rate of secondary
probing, likely due to the complications of the primary procedure, such as cicatricial stenosis or false
passage formation [35,57].
5. Other Interventions
Several studies have investigated the clinical efficacy of other surgical interventions in the
management of both simple and complex CLNDO.
Nasolacrimal intubation is an invasive technique initially thought for the resolution of persistent
CLNDO, consisting of the placement of a silicone tube stent in one or both canaliculi [19,62]. Most of
the studies reported a resolution rate of silicon intubation treating complex CLNDO after failed
probing ranging from 62% to 100% [51,63–65]. Lacrimal tubes are usually left in situ for a variable
period from 2 to 6 months; however, a period of longer than 3 months of intubation has shown
a higher success rate in older children [1]. Moreover, the improvement in skills and experience and
the introduction of monocanalicular tubes has allowed clinicians to adopt this procedure in the
primary management of CLNDO [23,66]; in particular, PEDIG recruited children with CLNDO aged
6 months to 45 months in a multicenter, prospective, non-randomized study, to undergo primary
silicon intubation for a 2–5 month-period and found a success rate of 90% in patients not lost in terms
of follow-up. However, in spite of the remarkable results, there are still some limitations to the study:
firstly, no control group was reported, and secondly, the high rate of tube removal (41%) before the
2-month period indicates a high dropout rate due to the low compliance of the patients [23].
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In addition, several studies reported better efficacy and compliance of monocanalicular intubation
than bicanicular intubation because the former procedure allows a simpler insertion of the tube and
avoids sedation during stent removal [67–69]. Moreover, a recent retrospective study published by
Eustis et al. investigating 186 eyes with CNLDO reported a higher success rate of monocanilicular
intubation in comparison with bicanalicular intubation (93.18% vs. 78.75%, p = 0.00653) [70]. Furthermore,
in the above-mentioned study published by Napier et al., a resolution rate of 92% with intubation
as a secondary intervention was shown in comparison with 67% in patients treated with repeated
probing [55].
Although nasolacrimal intubation has shown considerable results in the management of CLNDO,
the invasiveness of this procedure is by necessity associated with some complications, such as the
already-mentioned significant dropout rate, damage of the puncta, corneal or conjunctival abrasions and
granuloma formation, and thus, should be regarded more as an effective second-line strategy [20,23,65,71].
Balloon catheter dilatation is a more recent procedure which works by dilating the NLD
through balloon inflation and was shown to reduce the probing-induced complications [72,73].
In a non-randomized, prospective, multicenter study by PEDIG enrolling 159 children aged 6 to
48 months after failed probing, balloon catheter dilation demonstrated a resolution rate of 77%
(95% CI = 65% to 85%) in comparison with 88% of the intubation group (CI = 74% to 91%) over
a 6-month follow-up period [74]. A recent study published by Hu et al. reported a comparable success
rate displayed by both balloon cathether dilatation and nasolacrimal intubation (90.3% vs. 87.6%);
however, the former exerted a stronger efficacy in the resolution of complex CLNDO in comparison
with intubation (86.1% vs. 64.7%) [75].
Hence, given also the high cost of the equipment required for the procedure, balloon catheter
dilatation should be considered an efficient treatment modality in the management of complex cases
of CLNDO [31].
If all these multiple procedures have produced no results, or there are still complex
cases of bony obstruction, dacryocystocele and dacryocystitis, the last resort for patients is the
dacryocystorhinostomy surgical procedure [76,77]. In this respect, the more recent endoscopic
technique has improved the success rate of the procedure and decreased postoperative complications
due to the external approach, reducing the postoperative course [78,79]. See Table 1.
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Table 1. Clinical efficacy comparison between the treatment modalities in the management of congenital nasolacrimal duct obstruction (CLNDO) following the criteria
set by Oxford-Centre for level of Evidence-Based medicine and grade of recommendations Assessment, Development and Evaluation (GRADE).
Treatment Modality Pros Cons Levels ofEvidence
Grade of
Recommendations
Simple observation [15,19]
High compliance for the patients No
invasiveness Good spontaneous
resolution rate
Alone less effective than Crigler massage.
Prolonged time less efficacy of probing 1a B
Nasolacrimal sac
massage [25,30]
High compliance, no invasiveness,
Increased spontaneous resolution rate Prolonged time less efficacy of probing 1a A
Antibiotics [17,31] Efficacy with symptoms of infection No efficacy in CLNDO management 1c D
Early probing [9,40,46] High CLNDO success rate,No general anesthesia
Invasive procedure in children who could resolve
spontaneously CLNDO 1a A
Late probing [9,54]
High CLNDO success rate even in children
older than 1 year. Possibility to wait for
spontaneous CLDNO resolution
Invasive procedure under general anesthesia,
experienced ophthalmologist required 1a A
Repeat probing [61] Simple second-line invasive strategy Lower efficacy than primary probing 1a C
Nasolacrimal duct
intubation [66,70]
High success rate after failed probing,
especially monocanalicular tube
Invasive, general anesthesia required, High
dropout rate 1a B
Balloon catheter
dilatation [73,74] High success rate after failed probing
Invasive procedure, General anesthesia High
equipment cost 1a B
Dacryocystohinostomy [78,80] High success rate for complex CLNDOespecially with endoscopic procedure
Invasive procedure General Anesthesia
Postoperative complications High equipment cost 1c B
Grade of recommendations: A = High; B = Moderate; C = low; D = Very Low; Levels of Evidence: 1a = Systematic reviews (with homogeneity) of randomized controlled trials; 1c = All or
none randomized controlled trials.
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6. Conclusions
CLNDO is a relatively common disorder in the pediatric population (5–20%), mainly due to the
persistence of a membrane in the distal portion of the NLD. The higher association with anisometropic
amblyopia should not be neglected, and therefore, children with CLNDO should be followed up with
a comprehensive eye examination for at least 3 or 4 years.
The medical management of the disorder has revealed a high success rate; in fact obstructin
usually resolves with a conservative approach within the first year of age in two-thirds of children;
for this purpose, parents should be properly instructed to perform a correct Crigler maneuver 2–4 times
a day, in order to increase the chances of a CLNDO spontaneous resolution. Moreover, given the
possibility of spontaneous resolution also beyond the first year, a rational choice could be postponing
invasive treatment even after 15–18 months of age. On the contrary, there is no evidence about the
efficacy of antibiotics in the resolution of CLNDO, and for this reason, they should be administered
only in the case of clinical evidence of infection.
Probing is considered the first-line invasive treatment for CLNDO; more specifically, early probing
in the office has shown comparable results with late probing under general anesthesia in a surgical
facility, which can be performed with decent results within 3 years of age. Hence, given this evidence,
it is reasonable to prolong the conservative management of CLNDO as long as possible and to shift to
the invasive procedure when the former strategy has failed.
However, both early and late probing have been described as efficient and relatively safe treatment
modalities for the patients. Some ophthalmologists may adopt nasolacrimal intubation as a first-line
strategy in the management of CLNDO.
Furthermore, in the case of probing failure, balloon catheter intubation and endoscopic
dacryocystorhinostomy, as a last resort, have proven to be viable and effective second-line
treatment options.
Conflicts of Interest: The authors declare no conflicts of interest.
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